CD8A and neoplasm: Our study demonstrated that luteolin effectively inhibited tumour growth in H22 tumour‐bearing mice; sustained high levels of CD8+ T lymphocytes in the spleen, peripheral blood and tumour; and boosted their cytotoxicity in tumour tissues.